412 related articles for article (PubMed ID: 29282599)
21. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
22. Defining "Complete Cytoreduction" After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis.
Munoz-Zuluaga CA; King MC; Diaz-Sarmiento VS; Studeman K; Sittig M; MacDonald R; Nieroda C; Zambrano-Vera K; Gushchin V; Sardi A
Ann Surg Oncol; 2020 Dec; 27(13):5026-5036. PubMed ID: 32705513
[TBL] [Abstract][Full Text] [Related]
23. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.
Lopez-Ramirez F; Gushchin V; Sittig M; King MC; Baron E; Nikiforchin A; Nieroda C; Sardi A
Ann Surg Oncol; 2022 Jun; 29(6):3390-3401. PubMed ID: 35133518
[TBL] [Abstract][Full Text] [Related]
24. Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.
Enomoto LM; Choudry MH; Bartlett DL; Totin L; Mann GN; Skitzki JJ; Perry KC; Votanopoulos KI; Levine EA; Shen P
Ann Surg Oncol; 2020 Jan; 27(1):107-114. PubMed ID: 31368017
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix.
Tsang ES; McConnell YJ; Schaeffer DF; Lee L; Yin Y; Zerhouni S; Schaff K; Speers C; Kennecke HF
Ann Surg Oncol; 2018 Aug; 25(8):2391-2399. PubMed ID: 29916007
[TBL] [Abstract][Full Text] [Related]
26. Management and prognostic prediction of appendiceal mucinous adenocarcinoma with peritoneal metastasis: a single center study in China.
Ma R; Wang B; Zhai X; Lu Y; Xu H
BMC Cancer; 2020 Apr; 20(1):280. PubMed ID: 32252683
[TBL] [Abstract][Full Text] [Related]
27. Long-term Survival and Propensity Score Matched Outcomes of Bilateral
Singh B; Singh G; Pourgholami M; Alzahrani N; Morris DL
Anticancer Res; 2018 Oct; 38(10):5917-5921. PubMed ID: 30275219
[TBL] [Abstract][Full Text] [Related]
28. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D; Kusamura S; Milione M; Bruno F; Guaglio M; Deraco M
Ann Surg Oncol; 2018 Feb; 25(2):404-413. PubMed ID: 29159742
[TBL] [Abstract][Full Text] [Related]
29. Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix.
Sparks DS; Morris B; Xu W; Fulton J; Atkinson V; Meade B; Lutton N
Int Surg; 2015 Jan; 100(1):21-8. PubMed ID: 25594636
[TBL] [Abstract][Full Text] [Related]
30. Perioperative systemic chemotherapy for peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery & HIPEC.
Spiliotis J; Kopanakis N; Efstathiou E; Vassiliadou D; Argiriou O; Rogdakis A; Valavanis C
J BUON; 2017; 22(3):783-789. PubMed ID: 28730790
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer.
Cornali T; Sammartino P; Kopanakis N; Christopoulou A; Framarino Dei Malatesta M; Efstathiou E; Spagnoli A; Ciardi A; Biacchi D; Spiliotis J
Ann Surg Oncol; 2018 Mar; 25(3):679-687. PubMed ID: 29282600
[TBL] [Abstract][Full Text] [Related]
32. ASO Author Reflections: The Diminishing Role of Adjuvant HIPEC.
Enomoto LM; Shen P
Ann Surg Oncol; 2020 Jan; 27(1):115-116. PubMed ID: 31720936
[No Abstract] [Full Text] [Related]
33. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
[TBL] [Abstract][Full Text] [Related]
34. Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC.
Low RN; Barone RM; Lee MJ
Ann Surg Oncol; 2013 Apr; 20(4):1074-81. PubMed ID: 23456382
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis.
Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA
Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Garach NR; Kusamura S; Guaglio M; Bartolini V; Deraco M; Baratti D
Eur J Surg Oncol; 2021 May; 47(5):1132-1139. PubMed ID: 33280949
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms.
Evans T; Aziz O; Chakrabarty B; Wilson MS; Malcomson L; Lavelle C; O'Dwyer ST
Eur J Surg Oncol; 2021 Jan; 47(1):188-193. PubMed ID: 33092969
[TBL] [Abstract][Full Text] [Related]
38. The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Milovanov V; Sardi A; Studeman K; Nieroda C; Sittig M; Gushchin V
Ann Surg Oncol; 2016 Jun; 23(6):1928-33. PubMed ID: 26714951
[TBL] [Abstract][Full Text] [Related]
39. Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study.
Madsen AH; Ladekarl M; Villadsen GE; Grønbæk H; Sørensen MM; Stribolt K; Verwaal VJ; Iversen LH
Ann Surg Oncol; 2018 Feb; 25(2):422-430. PubMed ID: 29214450
[TBL] [Abstract][Full Text] [Related]
40. Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification.
Bhatt A; Mishra S; Prabhu R; Ramaswamy V; George A; Bhandare S; Shah M; Mehta S
Eur J Surg Oncol; 2018 Jul; 44(7):1105-1111. PubMed ID: 29685759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
